Researchers at UC Berkeley have used long-term human brain organoids to show that hyperreactive astrocytes may drive the ...

A novel inflammasome inhibitor derived from HIV antivirals has reversed established neurological deficits in a preclinical MS ...

A preclinical study published in Myeloid Cells reports that AS01, a vaccine adjuvant system, can induce trained immunity in human monocytes and reduce tumour growth in selected mouse cancer models.

Mayo Clinic researchers have shown that approved thyroid cancer drugs can restore a key antigen on aggressive tumour cells, making them visible once more to CAR T cells and improving treatment ...

A protein can look very different in disease without a single change to its sequence. Measuring these structural changes ...

City of Hope researchers have developed a modular 'plug-and-play' CAR T-cell platform that enables post-infusion ...

Co-Founder and Chief Technology Officer, Immuto Scientific Dan Benjamin is a technology developer who leads Immuto Scientific’s high-throughput structural proteomics and AI integration efforts for ...

Luca Lotta, MD, PhD, is Vice President and Chief Translational Genetics Officer at the Regeneron Genetics Center (RGC), where ...

University of Washington researchers have used stem cell-derived kidney organoids to uncover inflammatory pathways that drive ...

Scientists at National Jewish Health have identified oestrogen receptor alpha as a potential therapeutic target for ...

Finding the right drug target remains one of discovery's biggest challenges. Human genetics is helping researchers strengthen ...

Combining the BCG vaccine with a B-cell-targeting immunotherapy significantly reduced tuberculosis relapse rates in ...